Qiagen To Ramp Up Production Of Kits Used In Coronavirus Detection

In response to the rising demand for tests that detect the SARS-CoV-2 coronavirus, Qiagen plans to increase the output of its viral RNA extraction kits by as much as 50-fold compared to the company’s previous output. According to 2019 figures, Qiagen supported approximately 400,000 tests a month with its RNA nucleic extraction reagents; this number was down compared to its historical capacity of supplying 1.5 million tests a month...